MENUNews Archive
Date: 07/16/2014
The number of younger men diagnosed with prostate cancer has increased nearly 6-fold in the last 20 years, and the disease is more likely to be aggressive in these younger men, according to a new analysis.
Date: 06/25/2014
African-Americans with colon cancer are half as likely as Caucasian patients to have a type of colon cancer that is linked to better outcomes. The finding may provide insight into why African-Americans are more likely to die of colon cancer than Caucasians with the same stage of disease.
Date: 06/10/2014
In the last 30 years, since mammography was introduced, late-stage breast cancer incidence has decreased by 37 percent, a new study from the University of Michigan Comprehensive Cancer Center finds.
Date: 05/31/2014
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study.
Date: 05/23/2014
The information on this page has expired. Learn more about pancreatic cancer treatment and research on our pancreatic cancer webpages.
Date: 05/22/2014
About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, a new study finds.
Date: 05/19/2014
The information on this page has expired. Learn more about pancreatic cancer treatment and research on our pancreatic cancer webpages.
Date: 05/09/2014
A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells. The researchers are now looking at potential drugs that might target this process directly.
Date: 04/28/2014
Researchers surveyed woman in Detroit and Los Angeles who had been diagnosed with early stage breast cancer. They narrowed their sample to the 746 women who reported working at the time they were diagnosed. Participants were surveyed about nine months after diagnosis, and then given a follow-up survey about four years later.
Date: 04/24/2014
Prostate cancer becomes deadly when anti-hormone treatments stop working. Now a new study suggests a way to block the hormones at their entrance.
Researchers from the University of Michigan Rogel Cancer Center have found that a protein called BET bromodomain protein 4 binds to the hormone androgen receptor downstream of where current therapies work – targeting androgen receptor signaling.